Intelligent Bio Solutions Inc. (INBS)
INBS moved a median of -0.55% 30 minutes after news, and -1.99% by the close. How INBS actually reacts to news — the realized, point-in-time move the market made, measured across 312 labeled events over the last three years with zero look-ahead.
INBS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 310 |
| 30-min | -0.55% | 43% | 312 |
| 60-min | -1.04% | 37% | 312 |
| to close | -1.99% | 37% | 306 |
| Middle 50% of INBS reactions | -3.18% to +1.52% |
|---|---|
| Median reaction (30-min) | -0.55% |
| Measured reactions | 312 |
Half of all Intelligent Bio Solutions Inc. news events land between -3.18% and +1.52% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when INBS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to INBS's baseline. Nothing else.
Recent INBS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K INTELLIGENT BIO SOLUTION For: Oct 12 | SEC filing · Form 8-K | SEC EDGAR | -0.73% | +6.62% | |
| Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET | Press release | GlobeNewswire | -1.34% | -2.23% | |
| Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance | Press release | GlobeNewswire | +0.00% | +4.19% | |
| Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission | Press release | GlobeNewswire | -5.80% | +1.25% | |
| Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules | Press release | GlobeNewswire | -5.80% | +1.25% | |
| Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth | Press release | GlobeNewswire | -3.99% | -18.10% | |
| Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification | Press release | GlobeNewswire | +1.98% | +17.83% | |
| Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System | Press release | GlobeNewswire | +3.00% | +2.50% | |
| Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission | Press release | GlobeNewswire | +1.22% | +1.71% | |
| Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System | Press release | GlobeNewswire | -0.27% | -1.62% | |
| Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry | Press release | GlobeNewswire | +1.08% | +0.56% | |
| Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market | Press release | GlobeNewswire | +1.78% | -8.12% | |
| Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Press release | GlobeNewswire | +2.59% | -0.86% | |
| Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 | Press release | GlobeNewswire | +0.42% | +2.50% | |
| Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission | Press release | GlobeNewswire | +1.90% | +1.20% | |
| Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year | Press release | GlobeNewswire | +7.14% | +14.00% | |
| Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results | Press release | GlobeNewswire | -1.77% | +3.90% | |
| Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified | Press release | GlobeNewswire | +1.79% | -5.00% | |
| Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market | Press release | GlobeNewswire | +0.72% | -1.08% | |
| Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant | Press release | GlobeNewswire | +0.00% | +3.66% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | -5.01% | -9.79% | |
| Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry | Press release | GlobeNewswire | -5.01% | -9.79% | |
| Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout | Press release | GlobeNewswire | -0.71% | -2.13% | |
| Form 10-Q INTELLIGENT BIO SOLUTION For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -4.67% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.67% | |
| Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year | Press release | GlobeNewswire | +0.00% | -4.67% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Feb 05 | SEC filing · Form 8-K | SEC EDGAR | +2.00% | -9.84% | |
| Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year | Press release | GlobeNewswire | +2.00% | -9.84% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Jan 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.67% | |
| Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market | Press release | GlobeNewswire | -1.10% | +0.22% | |
| Form EFFECT INTELLIGENT BIO SOLUTION | SEC filing · Form EFFECT | SEC EDGAR | +4.93% | -2.12% | |
| Form D INTELLIGENT BIO SOLUTION | SEC filing · Form D | SEC EDGAR | -0.86% | -3.64% | |
| Form S-3 INTELLIGENT BIO SOLUTION | SEC filing · Form S-3 | SEC EDGAR | -0.96% | -33.65% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | +10.81% | +15.61% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Dec 31 | SEC filing · Form 8-K | SEC EDGAR | +14.51% | +35.30% | |
| Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Press release | GlobeNewswire | +14.51% | +35.30% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Dec 31 | SEC filing · Form 8-K | SEC EDGAR | -3.88% | -1.38% | |
| Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Press release | GlobeNewswire | -3.88% | -1.38% | |
| Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | Press release | GlobeNewswire | +11.15% | +66.03% | |
| Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring | Press release | GlobeNewswire | +6.25% | +11.66% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Dec 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +10.58% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | +5.02% | +2.23% | |
| Intelligent Bio Solutions Inc. Announces Reverse Stock Split | Press release | GlobeNewswire | -15.41% | -16.78% | |
| Form S-8 INTELLIGENT BIO SOLUTION | SEC filing · Form S-8 | SEC EDGAR | -0.69% | -1.39% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | +0.08% | +1.61% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | +0.34% | -3.04% | |
| Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025 | Press release | GlobeNewswire | +0.56% | -4.01% | |
| Form 10-Q INTELLIGENT BIO SOLUTION For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.47% | -0.96% | |
| Form 8-K INTELLIGENT BIO SOLUTION For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.52% | — | |
| Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth | Press release | GlobeNewswire | +1.47% | -0.96% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the INBS section they belong to.
Where else INBS is measured.
INBS earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Intelligent Bio Solutions Inc.'s median reaction calculated?
Every labeled INBS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 312 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of INBS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does INBS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.